Pharmaceutical Technology - April 2024

Pharmaceutical Technology - April 2024

Issue link: https://www.e-digitaleditions.com/i/1519174

Contents of this Issue

Navigation

Page 8 of 18

Over 30% higher in protein expression and up to 50% reduction in process development time than legacy mRNA capping methods Achieve an optimal mRNA Cap-1 structure with the most robust CleanCap ® M6 cap analog by TriLink ® . For more information visit go.trilinkbiotech.com/cleancap/m6 The numbers don't lie

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - April 2024 - Pharmaceutical Technology - April 2024